Ontrak Inc. (OTRK)

$0.52505

Market is closed - opens 8 PM, 11 Dec 2023

Insights on Ontrak Inc.

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 2.51M → 3.71M (in $), with an average increase of 17.8% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 7 quarters, -20.05M → -6.41M (in $), with an average increase of 21.4% per quarter

  • Vs TXG

    In the last 1 year, 10x Genomics Inc has given 39.8% return, outperforming this stock by 117.1%

  • Vs HQY

    In the last 3 years, Ontrak Inc. has experienced a drawdown of -99.9%, however Healthequity Inc resisted the overall trend and outperformed by 32.9%

Performance

  • $0.51
    $0.55
    $0.53
    downward going graph

    4.72%

    Downside

    Day's Volatility :8.18%

    Upside

    3.64%

    downward going graph
  • $0.52
    $9.90
    $0.53
    downward going graph

    1.89%

    Downside

    52 Weeks Volatility :94.75%

    Upside

    94.65%

    downward going graph

Returns

PeriodOntrak Inc.Sector (Health Care)Index (Russel 2000)
3 Months
-40.41%
-0.7%
0.0%
6 Months
-81.77%
1.3%
0.0%
1 Year
-77.25%
-4.3%
-1.5%
3 Years
-99.85%
18.3%
-7.5%

Highlights

Market Capitalization
14.9M
Book Value
- $0.94
Dividend Share
0.0
Dividend Yield
2.62%
Earnings Per Share (EPS)
-8.03
Wall Street Target Price
2.5
Profit Margin
-261.48%
Operating Margin TTM
-109.39%
Return On Assets TTM
-57.03%
Return On Equity TTM
-714.32%
Revenue TTM
11.7M
Revenue Per Share TTM
2.47
Quarterly Revenue Growth YOY
30.7%
Gross Profit TTM
7.1M
EBITDA
-18.7M
Diluted Eps TTM
-8.03
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Ontrak Inc.(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 376.15%

Current $0.53
Target $2.50

Company Financials

FY17Y/Y Change
Revenue
7.7M
↑ 9.07%
Net Income
-13.6M
↓ 24.15%
Net Profit Margin
-176.3%
↑ 77.21%
FY18Y/Y Change
Revenue
15.2M
↑ 96.67%
Net Income
-14.2M
↑ 4.46%
Net Profit Margin
-93.64%
↑ 82.66%
FY19Y/Y Change
Revenue
35.1M
↑ 131.24%
Net Income
-26.2M
↑ 84.13%
Net Profit Margin
-74.56%
↑ 19.08%
FY20Y/Y Change
Revenue
82.8M
↑ 136.04%
Net Income
-22.7M
↓ 13.21%
Net Profit Margin
-27.42%
↑ 47.14%
FY21Y/Y Change
Revenue
84.1M
↑ 1.56%
Net Income
-37.1M
↑ 63.56%
Net Profit Margin
-44.15%
↓ 16.73%
FY22Y/Y Change
Revenue
14.5M
↓ 82.75%
Net Income
-51.6M
↑ 38.85%
Net Profit Margin
-355.33%
↓ 311.18%
Q2 FY22Q/Q Change
Revenue
3.9M
↓ 62.22%
Net Income
-15.1M
↓ 24.9%
Net Profit Margin
-385.81%
↓ 191.74%
Q3 FY22Q/Q Change
Revenue
2.8M
↓ 27.16%
Net Income
-12.8M
↓ 15.23%
Net Profit Margin
-448.96%
↓ 63.15%
Q4 FY22Q/Q Change
Revenue
2.5M
↓ 11.71%
Net Income
-11.3M
↓ 11.13%
Net Profit Margin
-451.95%
↓ 2.99%
Q1 FY23Q/Q Change
Revenue
2.5M
↑ 0.0%
Net Income
-9.1M
↓ 19.73%
Net Profit Margin
-362.79%
↑ 89.16%
Q2 FY23Q/Q Change
Revenue
3.0M
↑ 17.93%
Net Income
-6.8M
↓ 25.81%
Net Profit Margin
-228.24%
↑ 134.55%
Q3 FY23Q/Q Change
Revenue
3.7M
↑ 25.51%
Net Income
-6.4M
↓ 5.0%
Net Profit Margin
-172.76%
↑ 55.48%
FY17Y/Y Change
Total Assets
6.6M
↑ 112.76%
Total Liabilities
5.7M
↓ 79.93%
FY18Y/Y Change
Total Assets
6.3M
↓ 4.25%
Total Liabilities
15.3M
↑ 167.93%
FY19Y/Y Change
Total Assets
23.9M
↑ 277.27%
Total Liabilities
47.8M
↑ 212.43%
FY20Y/Y Change
Total Assets
144.7M
↑ 506.59%
Total Liabilities
84.0M
↑ 75.76%
FY21Y/Y Change
Total Assets
93.7M
↓ 35.26%
Total Liabilities
48.1M
↓ 42.67%
FY22Y/Y Change
Total Assets
25.8M
↓ 72.51%
Total Liabilities
20.1M
↓ 58.28%
Q2 FY22Q/Q Change
Total Assets
34.9M
↓ 62.7%
Total Liabilities
15.2M
↓ 68.39%
Q3 FY22Q/Q Change
Total Assets
30.7M
↓ 12.26%
Total Liabilities
17.5M
↑ 14.74%
Q4 FY22Q/Q Change
Total Assets
25.8M
↓ 15.99%
Total Liabilities
20.1M
↑ 15.05%
Q1 FY23Q/Q Change
Total Assets
25.8M
↑ 0.0%
Total Liabilities
20.1M
↑ 0.0%
Q2 FY23Q/Q Change
Total Assets
22.6M
↓ 12.22%
Total Liabilities
21.9M
↑ 8.83%
Q3 FY23Q/Q Change
Total Assets
20.8M
↓ 8.15%
Total Liabilities
25.4M
↑ 16.21%
FY17Y/Y Change
Operating Cash Flow
-7.4M
↑ 28.68%
Investing Cash Flow
-413.0K
↑ 358.89%
Financing Cash Flow
11.7M
↑ 103.6%
FY18Y/Y Change
Operating Cash Flow
-8.6M
↑ 16.37%
Investing Cash Flow
62.0K
↓ 115.01%
Financing Cash Flow
7.3M
↓ 37.63%
FY19Y/Y Change
Operating Cash Flow
-16.9M
↑ 97.12%
Investing Cash Flow
-4.6M
↓ 7580.65%
Financing Cash Flow
27.3M
↑ 274.49%
FY20Y/Y Change
Operating Cash Flow
-6.3M
↓ 62.83%
Investing Cash Flow
-4.6M
↑ 0.0%
Financing Cash Flow
100.1M
↑ 266.05%
FY21Y/Y Change
Operating Cash Flow
-26.2M
↑ 316.35%
Investing Cash Flow
-4.5M
↓ 3.41%
Financing Cash Flow
-6.6M
↓ 106.62%
FY22Y/Y Change
Operating Cash Flow
-24.0M
↓ 8.37%
Investing Cash Flow
-1.2M
↓ 74.2%
Financing Cash Flow
-31.1M
↑ 369.32%
Q2 FY22Q/Q Change
Operating Cash Flow
-3.7M
↓ 75.25%
Investing Cash Flow
-499.0K
↑ 95.69%
Financing Cash Flow
-13.0M
↑ 310.31%
Q3 FY22Q/Q Change
Operating Cash Flow
-8.3M
↑ 123.01%
Investing Cash Flow
-250.0K
↓ 49.9%
Financing Cash Flow
5.6M
↓ 142.82%
Q4 FY22Q/Q Change
Operating Cash Flow
-1.4M
↓ 82.59%
Investing Cash Flow
-152.0K
↓ 39.2%
Financing Cash Flow
-623.0K
↓ 111.22%
Q1 FY23Q/Q Change
Operating Cash Flow
-1.4M
↑ 0.0%
Investing Cash Flow
-98.0K
↓ 35.53%
Financing Cash Flow
-623.0K
↑ 0.0%
Q2 FY23Q/Q Change
Operating Cash Flow
-5.1M
↑ 253.73%
Investing Cash Flow
-98.0K
↑ 0.0%
Financing Cash Flow
3.2M
↓ 618.94%

Technicals Summary

Sell

Neutral

Buy

Ontrak Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ontrak Inc.
Ontrak Inc.
-24.99%
-81.77%
-77.25%
-99.85%
-95.58%
10x Genomics Inc
10x Genomics Inc
34.47%
-12.55%
39.15%
-66.99%
-7.41%
Veeva Systems Inc.
Veeva Systems Inc.
3.89%
-9.33%
0.65%
-34.59%
91.03%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-2.13%
-12.46%
13.27%
13.27%
13.27%
Healthequity Inc
Healthequity Inc
-1.71%
6.85%
8.7%
5.96%
1.02%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ontrak Inc.
Ontrak Inc.
NA
NA
NA
0.0
-7.14
-0.57
0.03
-0.94
10x Genomics Inc
10x Genomics Inc
NA
NA
NA
-2.12
-0.29
-0.12
0.0
6.31
Veeva Systems Inc.
Veeva Systems Inc.
53.18
53.18
1.27
4.18
0.15
0.05
0.0
25.85
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
20.65
20.65
16.14
3.79
0.15
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
457.8
457.8
1.47
1.33
0.01
0.02
0.0
22.77
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ontrak Inc.
Ontrak Inc.
Buy
$14.9M
-95.58%
NA
-261.48%
10x Genomics Inc
10x Genomics Inc
Buy
$5.4B
-7.41%
NA
-37.79%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$28.4B
91.03%
53.18
24.2%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$31.7B
13.27%
20.65
8.91%
Healthequity Inc
Healthequity Inc
Buy
$5.9B
1.02%
457.8
1.37%

Institutional Holdings

  • Vanguard Group Inc

    2.45%

  • BlackRock Inc

    0.41%

  • Geode Capital Management, LLC

    0.36%

  • HRT FINANCIAL LLC

    0.28%

  • National Asset Management Inc

    0.23%

  • Morgan Stanley - Brokerage Accounts

    0.16%

Corporate Announcements

  • Ontrak Inc. Earnings

    Ontrak Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

ontrak, inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. its ontrak pre (predict-recommend-engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. the company's technology-enabled, ontrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, copd, and congestive heart failure. the ontrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. the company

Organization
Ontrak Inc.
Employees
118
CEO
Mr. Terren S. Peizer
Industry
Health Services

Discover More

FAQs